Shattuck Labs, Inc. (STTK)
5.655
-0.20
(-3.50%)
USD |
NASDAQ |
Oct 07, 16:00
5.65
0.00 (0.00%)
After-Hours: 20:00
Shattuck Labs Enterprise Value : 363.98M for Oct. 7, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 363.98M |
| October 06, 2026 | 384.63M |
| October 05, 2026 | 449.09M |
| October 02, 2026 | 472.26M |
| October 01, 2026 | 483.34M |
| September 30, 2026 | 481.32M |
| September 29, 2026 | 453.12M |
| September 28, 2026 | 442.04M |
| September 25, 2026 | 405.78M |
| September 24, 2026 | 429.95M |
| September 23, 2026 | 434.99M |
| September 22, 2026 | 449.09M |
| September 21, 2026 | 409.81M |
| September 18, 2026 | 399.73M |
| September 17, 2026 | 383.62M |
| September 16, 2026 | 386.64M |
| September 15, 2026 | 395.71M |
| September 14, 2026 | 418.87M |
| September 11, 2026 | 418.87M |
| September 10, 2026 | 413.84M |
| September 09, 2026 | 431.97M |
| September 08, 2026 | 449.09M |
| September 04, 2026 | 478.30M |
| September 03, 2026 | 495.42M |
| September 02, 2026 | 490.39M |
| Date | Value |
|---|---|
| September 01, 2026 | 486.36M |
| August 31, 2026 | 500.46M |
| August 28, 2026 | 503.48M |
| August 27, 2026 | 564.92M |
| August 26, 2026 | 590.11M |
| August 25, 2026 | 606.22M |
| August 24, 2026 | 590.11M |
| August 21, 2026 | 552.84M |
| August 20, 2026 | 524.63M |
| August 19, 2026 | 565.93M |
| August 18, 2026 | 544.78M |
| August 17, 2026 | 538.74M |
| August 14, 2026 | 541.76M |
| August 13, 2026 | 531.69M |
| August 12, 2026 | 548.81M |
| August 11, 2026 | 517.58M |
| August 10, 2026 | 513.55M |
| August 07, 2026 | 526.65M |
| August 06, 2026 | 515.57M |
| August 05, 2026 | 536.72M |
| August 04, 2026 | 592.12M |
| August 03, 2026 | 528.66M |
| July 31, 2026 | 506.50M |
| July 30, 2026 | 518.59M |
| July 29, 2026 | 475.28M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.500B |
| Alnylam Pharmaceuticals, Inc. | 29.69B |
| Savara, Inc. | 859.72M |
| Vericel Corp. | 2.017B |
| Biogen, Inc. | 39.88B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.15M |
| Total Expenses (Quarterly) | 15.15M |
| EPS Diluted (Quarterly) | -0.1168 |
| Earnings Yield | -9.00% |
| Normalized Earnings Yield | -8.990 |